Tag: KEYNOTE-042
Oncology Trials Could Benefit From Increased Data on Tobacco Use
By Leah Lawrence
Posted: June 24, 2020
As part of its declaration on tobacco cessation after cancer diagnosis, the IASLC recommended that smoking status, both initially...
Single-Agent Pembrolizumab Active Against STK11– and KEAP1– Mutated NSCLC According to...
By Kara Nyberg, PhD
Posted: June 24, 2020
Genomic alterations in STK11 and KEAP1 represent two of the most common and potent contributors to a cold...
